VoxCell BioInnovation and adMare BioInnovations have launched a research partnership focused on validating antibody-based cancer therapies using advanced bioprinted human tissue models designed to improve predictive drug testing and accelerate oncology innovation.
AdMare BioInnovations | 15/05/2026 | By News Bureau
BELLUS Health Inc.is pleased to announce that it has closed the transaction announced on March 23, 2020 in accordance with the asset purchase and sale agreement entered into with adMare BioInnovations’ NEOMED Institute
AdMare BioInnovations | 27/03/2020 | By Darshana | 552
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy